EPS Diluted (Annual) Chart

Historical EPS Diluted (Annual) Data

View and export this data back to 1996. Start Trial.
Date Value
December 31, 2025 -0.2262
December 31, 2024 -2.927
December 31, 2023 -4.510
December 31, 2022 -10.73
December 31, 2021 -8.086
December 31, 2020 -16.96
December 31, 2019 -46.51
December 31, 2018 -276.40
December 31, 2017 -2148.00
December 31, 2016 -84960.00
December 31, 2015 -24873.57
December 31, 2014 0.00
December 31, 2013 0.00
December 31, 2012 -14040.00
December 31, 2011 -23760.00
Date Value
December 31, 2010 -6480.00
December 31, 2009 -4320.00
December 31, 2008 -1080.00
December 31, 2007 -4320.00
December 31, 2006 -7560.00
December 31, 2005 -45360.00
December 31, 2004 -50760.00
December 31, 2003 -101520.0
December 31, 2002 -98280.00
December 31, 2001 -35640.00
December 31, 2000 -56160.00
December 31, 1999 -59154.16
December 31, 1998 -14040.00
December 31, 1997 -23760.00
December 31, 1996 0.00

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (Annual) Range, Past 5 Years

View EPS Diluted (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Annual) Benchmarks

View EPS Diluted (Annual) Benchmarks
Start Trial
NeoGenomics, Inc. -0.8433
Quest Diagnostics, Inc. 8.743
Labcorp Holdings, Inc. 10.46
OPKO Health, Inc. -0.3004
Psychemedics Corp. --